Ortin Global Ltd (NSE:ORTINGLOBE) Share Price

Company Profile

Business description
Ortin Global Ltd is an Indian company engaged in the manufacturing and trading of Pharmaceuticals, Drugs, and Intermediates. Its formulations include anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helminthics, analgesics and antipyretics, antibiotics, antifungal, cephalosporins, and others. Some of its API intermediates include Ciprofloxacin, Tramadol, Efavarenz, Lamivudine, Zidovudine, Nevirapine, Lopinavir, Fluconazole, Triclabendazole, Omeprazole, and others. Additionally, the company is also involved in the real estate business.
Contact
G Block
Plot No. C-66, 9th Floor, 915, One BKC
Bandra Kurla Complex
Bandra East
MumbaiMH400051
IND
https://www.ortinlabsindia.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
3

Recommended

From AI integration to capital expenditure increases, here’s what we expect in Alphabet’s earnings report.

Malik Ahmed Khan, CFA | 24 April 2026

Santos reports a solid quarter on the back of higher commodity prices - yet the shares look undervalued.

Mark Taylor | 24 April 2026

ChatGPT and large language models should be a tailwind for this company.

Simonelle Mody | 24 April 2026

Index	Last price	Change	% Change
All Ordinaries	8,990.80	20.60	0.23%
CAC 40	8,200.38	42.56	0.52%
DAX 40	24,318.31	189.33	0.78%
Dow JONES (US)	49,230.71	79.61	-0.16%
FTSE 100	10,385.60	6.52	0.06%
HKSE	25,925.65	52.42	-0.20%
NASDAQ	24,836.60	398.10	1.63%
Nikkei 225	60,537.36	821.18	1.38%
NZX 50 Index	12,874.94	9.99	-0.08%
S&P 500	7,165.08	56.68	0.80%
S&P/ASX 200	8,766.40	17.20	0.20%
SSE Composite Index	4,086.34	6.44	0.16%